All of the following are true regarding the structure and function of the neuromuscular junction EXCEPT:

## Structural Organization of the Neuromuscular Junction ### Correct Statements (Options 0, 1, 2) **Key Point:** The neuromuscular junction has three main compartments: presynaptic terminal, synaptic cleft, and postsynaptic motor end plate. **Option 0 — Acetylcholine Receptors on Motor End Plate:** - Nicotinic acetylcholine receptors are clustered at the crests of junctional folds - This clustering increases the density of receptors in the postsynaptic membrane - Ensures efficient signal transmission across the junction **Option 1 — Acetylcholinesterase in the Synaptic Cleft:** - Located on the basal lamina of the synaptic cleft - Rapidly hydrolyzes acetylcholine into choline and acetate - Termination of neuromuscular transmission depends on this enzyme - Inhibition of acetylcholinesterase (by anticholinesterases) prolongs acetylcholine action **Option 2 — Mitochondria in Presynaptic Terminal:** - Abundant mitochondria provide ATP for acetylcholine synthesis - Also power the Na⁺/K⁺-ATPase and vesicle recycling - Essential for sustained neuromuscular transmission ### Incorrect Statement (Option 3) — **THE ANSWER** **High-Yield:** Acetylcholine is synthesized **in the presynaptic terminal**, not in the synaptic cleft. - Choline acetyltransferase (ChAT) is located in the presynaptic axon terminal - Acetylcholine is synthesized from acetyl-CoA and choline - The neurotransmitter is then packaged into synaptic vesicles - Once released into the synaptic cleft, acetylcholine only undergoes hydrolysis by acetylcholinesterase ### Summary Table | Compartment | Key Molecules | Function | | --- | --- | --- | | **Presynaptic Terminal** | ChAT, Acetyl-CoA, Choline, Mitochondria | Acetylcholine synthesis and storage | | **Synaptic Cleft** | Acetylcholinesterase, Basal lamina | Acetylcholine hydrolysis and termination | | **Postsynaptic (Motor End Plate)** | Nicotinic AChR (clustered) | Signal reception and muscle depolarization | **Clinical Pearl:** Anticholinesterase drugs (e.g., neostigmine, pyridostigmine) inhibit acetylcholinesterase, prolonging acetylcholine action in the synaptic cleft — used therapeutically in myasthenia gravis.